Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NewFish partners with Socius Ingredients to develop algae proteins for USA sports and active nutrition market 2023-05-12 03:52
CytoMed Therapeutics to Ring Nasdaq Closing Bell 2023-05-11 21:00
Lunit to Present 16 Abstracts at the 2023 ASCO Annual Meeting 2023-05-10 13:44
CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology 2023-05-09 22:07
CABIO showcases the new products and Ready-to-Market solutions at Vitafoods Europe 2023 2023-05-09 20:10
The First International Conference On Single-Cell And Spatial Omics is held in Guangzhou, China: the Golden Age of Single Cell Analysis 2023-05-09 12:27
Singlera Genomics Receives FDA Breakthrough Device Designation for PDACatch, a Liquid Biopsy Assay for Pancreatic Cancer Detection in High-Risk Individuals 2023-05-08 22:00
PharmAbcine to participate in "BIO International Convention 2023" 2023-05-08 20:00
Biosion Presents Discovery and Development Data at PEGS for its Anti-CD40 Agonistic Antibody 2023-05-08 19:30
Neuro3 Therapeutics Acquires Exclusive Worldwide Rights to Develop and Commercialize Clinical Stage KCNQ2 Activators from Lundbeck 2023-05-08 14:00
BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701 2023-05-08 07:00
NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE 2023-05-08 04:00
Empowering Innovation to the Global Market with Acro Certify 2023-05-06 10:18
CARsgen's CLDN18.2 mAb AB011 Achieves IND Clearance from the NMPA for the First-line Combination Treatment of Gastric Cancer 2023-05-05 20:50
Arbele celebrates its 7th anniversary as a clinical-stage immunotherapy biotech and the opening of TibTech, its cancer diagnostics subsidiary 2023-05-05 15:00
Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery 2023-05-05 08:00
ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor 2023-05-05 01:00
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting 2023-05-03 12:00
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products 2023-04-29 23:20
ISS Collaboration - Singleron Biotechnologies GmbH joined the pursuit of "Reaching for the Stars" 2023-04-28 20:56
1 53 54 55 56 57 222